Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.

Journal: The Journal of infectious diseases
Published Date:

Abstract

BACKGROUND: It is unclear whether data-driven machine learning models, which are trained on large epidemiological cohorts, may improve prediction of comorbidities in people living with human immunodeficiency virus (HIV).

Authors

  • Jan A Roth
    1Division of Infectious Diseases and Hospital Epidemiology,University Hospital Basel,Basel,Switzerland.
  • Gorjan Radevski
    IBM Research-Zurich, Rüschlikon, Switzerland.
  • Catia Marzolini
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Andri Rauch
    University Clinic of Infectious Diseases, University Hospital Bern, University of Bern, Bern, Switzerland.
  • Huldrych F Günthard
    Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Roger D Kouyos
    Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Christoph A Fux
    Clinic for Infectious Diseases and Hospital Hygiene, Kantonsspital Aarau, Aarau, Switzerland.
  • Alexandra U Scherrer
    Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Alexandra Calmy
    Division of Infectious Diseases, University Hospital Geneva, University of Geneva, Geneva, Switzerland.
  • Matthias Cavassini
    Infectious Disease Service, Lausanne university hospital, University of Lausanne, Lausanne, Switzerland.
  • Christian R Kahlert
    Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.
  • Enos Bernasconi
    Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland.
  • Jasmina Bogojeska
    IBM Research-Zurich, Rüschlikon, Switzerland.
  • Manuel Battegay
    1Division of Infectious Diseases and Hospital Epidemiology,University Hospital Basel,Basel,Switzerland.